MBE-17647-24163
3 vaccinations
2 coded responses
25 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 523 / IA
- Registered
- 2020-12-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-16
Dose 1 — Pfizer-BioNTech
-
2020-12-17
Registered in v-safe
- 2020-12-17
- 2020-12-18
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-23
- 2020-12-30
-
2021-01-06
Survey response — day 21, dose 1MedDRA: Headache, Nausea — Feeling: FairFree text: Constant headache for more than 5 days, nauseaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-09
Dose 2 — Pfizer-BioNTech
-
2021-01-09
Health check-in — day 0, dose 2Feeling: Good · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-01-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Headache, NauseaAdult check-in
-
2021-01-11
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fever · Headache, Muscle or body aches, DiarrheaAdult check-in
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-16
- 2021-01-23
- 2021-01-30
- 2021-02-06
- 2021-02-20
- 2021-04-10
- 2021-07-12
- 2022-01-09
-
2022-01-13
Dose 3 — Pfizer-BioNTech
-
2023-01-13
Survey response — 12 months, dose 3MedDRA: Migraine, Office visit — Feeling: Good · Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11
-
2023-01-13
Report sent to call center — 12 months, dose 3Get care from a doctor or other healthcare professional1 call case(s)
- 2023-01-17
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-16 | Pfizer-BioNTech | |
| 2 | 2021-01-09 | Pfizer-BioNTech | |
| 3 | 2022-01-13 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 1 — day 21, dose 1
Symptoms: Constant headache for more than 5 days, nausea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release